TABLE 2.
Mechanisms Behind Altered PKs in Patients With Cirrhosis and PH
| Mechanism | Comments | |
|---|---|---|
|
| ||
| 1 | Reduced intrinsic capacity - Decreased enzyme levels - Decreased activity |
Liver disease etiology–specific variability in different CYPs may exist—for example, alcohol and infection can affect some CYPs selectively |
| 2 | Reduction in blood flow | May affect drug disposition through a number of mechanisms |
| 3 | Shunts | Intrahepatic shunts—may account for up to 65% of hepatic blood flow Spontaneous portosystemic shunts and TIPS can significantly modify |
| 4 | Changes in protein binding | Impacts delivery of drugs to hepatocytes and can also have an impact on PD response |
| 5 | Reduced delivery of oxygen | Oxygen is important for CYP activity |
| 6 | Altered transporter expression and function | Hepatocyte uptake as well as efflux into biliary canaliculi can be affected |
| 7 | Small bowel CYP activity | TIPS significantly reduces small bowel CYP3A activity |
| 8 | Drug-drug interactions | Altered PKs of one compound may have secondary effects on the PKs of coadminstered drugs |
| 9 | Impaired renal function | PKs of renally excreted drugs may be profoundly affected in individuals with cirrhosis |
| 10 | Altered intestinal absorption | There may be diminished absorption of orally administered drugs and may also influence the PKs of drugs which are bile excreted because of impaired enterohepatic circulation |
Abbreviations: CYP, cytochrome P450; TIPS, transjugular intrahepatic portosystemic shunts.